Notebook

MAD LEMURS A study of lemurs infected with bovine spongiform encephalopathy (BSE), clarifies the pathogenesis of the abnormal proteinase-resistant protein (PrP) or "prion" protein now thought to cause encephalopathic diseases. Also, more zoo animals could have the disease than previously thought (N. Bons et al., "Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents," Proceedings of the National Academy of Sciences, 96:4046-51, March 30, 1999)

Written byA. J. S. Rayl
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

MAD LEMURS A study of lemurs infected with bovine spongiform encephalopathy (BSE), clarifies the pathogenesis of the abnormal proteinase-resistant protein (PrP) or "prion" protein now thought to cause encephalopathic diseases. Also, more zoo animals could have the disease than previously thought (N. Bons et al., "Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents," Proceedings of the National Academy of Sciences, 96:4046-51, March 30, 1999). The study, which involved more than two dozen experimentally and spontaneously infected lemurs in France, confirms expectations from previous research about prion distribution and brain degeneration, explains National Institute of Neurological Disorders and Stroke (NINDS) researcher Paul Brown, senior author of the report. The 20 lemurs that were spontaneously infected came from three different French primate centers and were all fed beef protein dietary supplements made by a British company. Presumably, the researchers concluded, the beef used--cracklings or the "fifth quarter ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies